Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 149 No. 1920 (2019)

Cell therapies for skin regeneration: an overview of 40 years of experience in burn units

  • Philippe Abdel-Sayed
  • Murielle Michetti
  • Corinne Scaletta
  • Marjorie Flahaut
  • Nathalie Hirt-Burri
  • Anthony de Buys Roessingh
  • Wassim Raffoul
  • Lee A. Applegate
DOI
https://doi.org/10.4414/smw.2019.20079
Cite this as:
Swiss Med Wkly. 2019;149:w20079
Published
19.05.2019

Summary

The earliest attempts at cell therapy can be attributed to Charles-Edward Brown-Séquard (1817–1894), who sought to treat senescence and aging by injecting animal gonad shreds into his contemporaries, a practice that was widespread in late 19th century. Since then, advances in science have enabled the development of biological substitutes to restore the function of various tissues. Skin was one of the first tissues to be regenerated. For severe burns, patient survival depends on the restoration of skin function as a barrier against pathogens and control of body temperature and fluid loss. We aim here to overview the different cell therapy techniques implemented at the University Hospital of Lausanne (CHUV), one of the two Swiss national centres of highly specialised medicine for burn care. In particular, we will describe the specific indications for each of the different therapies as well as future perspectives.

References

  1. Meyer U, Meyer T, Handschel J, Wiesmann HP. Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin, Heidelberg: Springer; 2009.
  2. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet. 1999;354(Suppl 1):S32–4. doi:.https://doi.org/10.1016/S0140-6736(99)90247-7
  3. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6. doi:.https://doi.org/10.1126/science.8493529
  4. O’Brien FJ. Biomaterials & scaffolds for tissue engineering. Mater Today. 2011;14(3):88–95. doi:.https://doi.org/10.1016/S1369-7021(11)70058-X
  5. Berthiaume F, Maguire TJ, Yarmush ML. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng. 2011;2(1):403–30. doi:.https://doi.org/10.1146/annurev-chembioeng-061010-114257
  6. Huey DJ, Hu JC, Athanasiou KA. Unlike bone, cartilage regeneration remains elusive. Science. 2012;338(6109):917–21. doi:.https://doi.org/10.1126/science.1222454
  7. Khademhosseini A, Vacanti JP, Langer R. Progress in tissue engineering. Sci Am. 2009;300(5):64–71. doi:.https://doi.org/10.1038/scientificamerican0509-64
  8. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981;211(4486):1052–4. doi:.https://doi.org/10.1126/science.7008197
  9. Hernon CA, Dawson RA, Freedlander E, Short R, Haddow DB, Brotherston M, et al. Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med. 2006;1(6):809–21. doi:.https://doi.org/10.2217/17460751.1.6.809
  10. Lefrère JJ, Berche P. [Doctor Brown-Sequard’s therapy]. Ann Endocrinol (Paris). 2010;71(2):69–75. Article in French. doi:.https://doi.org/10.1016/j.ando.2010.01.003
  11. Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A. 2011;17(17-18):2221–30. doi:.https://doi.org/10.1089/ten.tea.2011.0131
  12. Madison KC. Barrier function of the skin: “la raison d’être” of the epidermis. J Invest Dermatol. 2003;121(2):231–41. doi:.https://doi.org/10.1046/j.1523-1747.2003.12359.x
  13. Breitkreutz D, Mirancea N, Nischt R. Basement membranes in skin: unique matrix structures with diverse functions? Histochem Cell Biol. 2009;132(1):1–10. doi:.https://doi.org/10.1007/s00418-009-0586-0
  14. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7. doi:.https://doi.org/10.1126/science.282.5391.1145
  15. Maleki M, Ghanbarvand F, Reza Behvarz M, Ejtemaei M, Ghadirkhomi E. Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells. 2014;7(2):118–26. doi:.https://doi.org/10.15283/ijsc.2014.7.2.118
  16. Western P. Foetal germ cells: striking the balance between pluripotency and differentiation. Int J Dev Biol. 2009;53(2-3):393–409. doi:.https://doi.org/10.1387/ijdb.082671pw
  17. Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006;22(1):339–73. doi:.https://doi.org/10.1146/annurev.cellbio.22.010305.104357
  18. Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32(6):1408–19. doi:.https://doi.org/10.1002/stem.1681
  19. Applegate LA, Scaletta C, Hirt-Burri N, Raffoul W, Pioletti D. Whole-cell bioprocessing of human fetal cells for tissue engineering of skin. Skin Pharmacol Physiol. 2009;22(2):63–73. doi:.https://doi.org/10.1159/000178865
  20. Ramelet AA, Hirt-Burri N, Raffoul W, Scaletta C, Pioletti DP, Offord E, et al. Chronic wound healing by fetal cell therapy may be explained by differential gene profiling observed in fetal versus old skin cells. Exp Gerontol. 2009;44(3):208–18. doi:.https://doi.org/10.1016/j.exger.2008.11.004
  21. Darwiche S, Scaletta C, Raffoul W, Pioletti DP, Applegate LA. Epiphyseal Chondroprogenitors Provide a Stable Cell Source for Cartilage Cell Therapy. Cell Med. 2012;4(1):23–32. doi:.https://doi.org/10.3727/215517912X639324
  22. Vuadens F, Crettaz D, Scelatta C, Servis C, Quadroni M, Bienvenut WV, et al. Plasticity of protein expression during culture of fetal skin cells. Electrophoresis. 2003;24(7-8):1281–91. doi:.https://doi.org/10.1002/elps.200390165
  23. Montjovent MO, Bocelli-Tyndall C, Scaletta C, Scherberich A, Mark S, Martin I, et al. In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. Tissue Eng Part A. 2009;15(7):1523–32. doi:.https://doi.org/10.1089/ten.tea.2008.0222
  24. De Buys Roessingh AS, Hohlfeld J, Scaletta C, Hirt-Burri N, Gerber S, Hohlfeld P, et al. Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant. 2006;15(8-9):823–34. doi:.https://doi.org/10.3727/000000006783981459
  25. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 1975;6(3):331–43. doi:.https://doi.org/10.1016/S0092-8674(75)80001-8
  26. Hartmann B, Ekkernkamp A, Johnen C, Gerlach JC, Belfekroun C, Küntscher MV. Sprayed cultured epithelial autografts for deep dermal burns of the face and neck. Ann Plast Surg. 2007;58(1):70–3. doi:.https://doi.org/10.1097/01.sap.0000250647.39784.bb
  27. Koch N, Erba P, Benathan M, Raffoul W. [New developments in skin reconstruction - cell cultures and skin substitutes plus review of the literature]. Ann Burns Fire Disasters. 2010;23(3):131–6. Article in French.
  28. Sheridan R. Closure of the excised burn wound: autografts, semipermanent skin substitutes, and permanent skin substitutes. Clin Plast Surg. 2009;36(4):643–51. doi:.https://doi.org/10.1016/j.cps.2009.05.010
  29. Sun BK, Siprashvili Z, Khavari PA. Advances in skin grafting and treatment of cutaneous wounds. Science. 2014;346(6212):941–5. doi:.https://doi.org/10.1126/science.1253836
  30. Hohlfeld J, de Buys Roessingh A, Hirt-Burri N, Chaubert P, Gerber S, Scaletta C, et al. Tissue engineered fetal skin constructs for paediatric burns. Lancet. 2005;366(9488):840–2. doi:.https://doi.org/10.1016/S0140-6736(05)67107-3
  31. Akhundov K, Pietramaggiori G, Waselle L, Darwiche S, Guerid S, Scaletta C, et al. Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters. 2012;25(4):207–13.
  32. Guerid S, Darwiche SE, Berger MM, Applegate LA, Benathan M, Raffoul W. Autologous keratinocyte suspension in platelet concentrate accelerates and enhances wound healing - a prospective randomized clinical trial on skin graft donor sites: platelet concentrate and keratinocytes on donor sites. Fibrogenesis Tissue Repair. 2013;6(1):8. doi:.https://doi.org/10.1186/1755-1536-6-8
  33. Dimitropoulos G, Jafari P, de Buys Roessingh A, Hirt-Burri N, Raffoul W, Applegate LA. Burn patient care lost in good manufacturing practices? Ann Burns Fire Disasters. 2016;29(2):111–5.
  34. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–34. doi:.https://doi.org/10.1038/jid.2013.446
  35. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367–75. doi:.https://doi.org/10.1056/NEJMra1615439
  36. Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P&T. 2015;40(5):344–52.
  37. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P&T. 2015;40(4):277–83.
  38. Gonzalez MR, Ducret V, Leoni S, Fleuchot B, Jafari P, Raffoul W, et al. Transcriptome Analysis of Pseudomonas aeruginosa Cultured in Human Burn Wound Exudates. Front Cell Infect Microbiol. 2018;8:39. doi:.https://doi.org/10.3389/fcimb.2018.00039
  39. Abdel-Sayed P, Kaeppeli A, Siriwardena T, Darbre T, Perron K, Jafari P, et al. Anti-Microbial Dendrimers against Multidrug-Resistant P. aeruginosa Enhance the Angiogenic Effect of Biological Burn-wound Bandages. Sci Rep. 2016;6(1):22020. doi:.https://doi.org/10.1038/srep22020
  40. Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017;551(7680):327–32. doi:.https://doi.org/10.1038/nature24487
  41. Marks P, Gottlieb S. Balancing Safety and Innovation for Cell-Based Regenerative Medicine. N Engl J Med. 2018;378(10):954–9. doi:.https://doi.org/10.1056/NEJMsr1715626
  42. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12(12):1397–402. doi:.https://doi.org/10.1038/nm1504